These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37214181)

  • 1. Thrombotic thrombocytopenic purpura following ChAdOx1 nCov-19 vaccination: A case report.
    Shateri Amiri B; Radkhah H; Taslimi R; Shahbazi Dastjerdi Z; Khadembashiri MM; Gholizadeh Mesgarha M; Rahimipour Anaraki S
    IDCases; 2023; 32():e01795. PubMed ID: 37214181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
    Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
    BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired thrombotic thrombocytopenic purpura after AstraZeneca vaccine: A case report.
    Yaghoubi F; Dalil D
    Caspian J Intern Med; 2022; 13(Suppl 3):299-302. PubMed ID: 35872667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic thrombocytopenic purpura after ChAdOx1 nCoV-19 vaccine.
    Lee HP; Selvaratnam V; Rajasuriar JS
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34625443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
    Saluja P; Gautam N; Yadala S; Venkata AN
    Thromb Res; 2022 Jun; 214():115-121. PubMed ID: 35533526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of Thrombotic Thrombocytopenic Purpura After Vaccination with mRNA-1273 COVID-19 vaccine.
    Ntelis S; Champ K
    J Community Hosp Intern Med Perspect; 2022; 12(4):80-84. PubMed ID: 36262899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired Thrombotic Thrombocytopenic Purpura After BNT162b2 COVID-19 Vaccine: Case Report and Literature Review.
    Hammami E; Lamarque M; Aujoulat O; Debliquis A; Drénou B; Harzallah I
    Lab Med; 2022 Nov; 53(6):e145-e148. PubMed ID: 35482291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic Thrombocytopenic Purpura After Ad6.COV2.S Vaccination.
    Ramanan S; Singh H; Menon P; Patel PM; Parmar V; Malik D
    Cureus; 2022 Aug; 14(8):e28592. PubMed ID: 36185943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired Thrombotic Thrombocytopenic Purpura Following Inactivated COVID-19 Vaccines: Two Case Reports and a Short Literature Review.
    Ben Saida I; Maatouk I; Toumi R; Bouslama E; Ben Ismail H; Ben Salem C; Boussarsar M
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccine in an older patient: Minireview and a case report.
    Luciano PQ; Binatti R; Sodré AR; Zajac SR; Marson FAL; Ortega MM
    J Infect Public Health; 2022 Jun; 15(6):638-642. PubMed ID: 35580449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic thrombocytopenic purpura developed after pegylated interferon treatment for hepatitis B infection.
    Mei S; Feng Y; Cui L; Chen J; Mao Z; Zhao X; Mei C; Qian Y
    BMC Nephrol; 2022 Dec; 23(1):400. PubMed ID: 36513992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac.
    Long Z; Jiang S; Xin H; Zhang L; Lu R; Liu F; Xu Y; Wang L; Wang J; Zhang X; Liao H; Shi J; Yan X; Zhu X; Shao R; Li Z; Zhu Y; Yan H; Wu J; Fang C; Xi X; Shi X
    Front Med; 2024 Aug; 18(4):744-751. PubMed ID: 38958922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and thrombotic thrombocytopenic purpura: A case report.
    Mushtaq MZ; Zafar Mahmood SB; Ali SA; Shaikh MU
    J Pak Med Assoc; 2023 Feb; 73(2):407-409. PubMed ID: 36800739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.
    Maayan H; Kirgner I; Gutwein O; Herzog-Tzarfati K; Rahimi-Levene N; Koren-Michowitz M; Blickstein D
    J Thromb Haemost; 2021 Sep; 19(9):2314-2317. PubMed ID: 34105247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura: A case report.
    Chaurasiya PS; Khatri A; Gurung S; Karki S; Shahi S; Aryal L
    Ann Med Surg (Lond); 2022 Oct; 82():104789. PubMed ID: 36268380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Rare Case of Severe Manifestation of COVID-19 Infection Presenting as Immune-Related Thrombotic Thrombocytopenic Purpura With Multiorgan Involvement Treated With Plasmapheresis, Steroids, Rituximab, and Caplacizumab.
    Mandyam S; Fatmi SS; Banzon G; Kaur P; Katamreddy Y; Parghi D; Farooq A; Liaqat H; Basarakodu K
    Cureus; 2022 Jul; 14(7):e26961. PubMed ID: 35989829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
    Li G; Cappuccini F; Marchevsky NG; Aley PK; Aley R; Anslow R; Bibi S; Cathie K; Clutterbuck E; Faust SN; Feng S; Heath PT; Kerridge S; Lelliott A; Mujadidi Y; Ng KF; Rhead S; Roberts H; Robinson H; Roderick MR; Singh N; Smith D; Snape MD; Song R; Tang K; Yao A; Liu X; Lambe T; Pollard AJ;
    Lancet; 2022 Jun; 399(10342):2212-2225. PubMed ID: 35691324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
    Voysey M; Costa Clemens SA; Madhi SA; Weckx LY; Folegatti PM; Aley PK; Angus B; Baillie VL; Barnabas SL; Bhorat QE; Bibi S; Briner C; Cicconi P; Clutterbuck EA; Collins AM; Cutland CL; Darton TC; Dheda K; Dold C; Duncan CJA; Emary KRW; Ewer KJ; Flaxman A; Fairlie L; Faust SN; Feng S; Ferreira DM; Finn A; Galiza E; Goodman AL; Green CM; Green CA; Greenland M; Hill C; Hill HC; Hirsch I; Izu A; Jenkin D; Joe CCD; Kerridge S; Koen A; Kwatra G; Lazarus R; Libri V; Lillie PJ; Marchevsky NG; Marshall RP; Mendes AVA; Milan EP; Minassian AM; McGregor A; Mujadidi YF; Nana A; Padayachee SD; Phillips DJ; Pittella A; Plested E; Pollock KM; Ramasamy MN; Ritchie AJ; Robinson H; Schwarzbold AV; Smith A; Song R; Snape MD; Sprinz E; Sutherland RK; Thomson EC; Török ME; Toshner M; Turner DPJ; Vekemans J; Villafana TL; White T; Williams CJ; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
    Lancet; 2021 Mar; 397(10277):881-891. PubMed ID: 33617777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic Thrombocytopenic Purpura Presentation in an Elderly Gentleman Following COVID Vaccine Circumstances.
    Chamarti K; Dar K; Reddy A; Gundlapalli A; Mourning D; Bajaj K
    Cureus; 2021 Jul; 13(7):e16619. PubMed ID: 34447649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired Thrombotic Thrombocytopenic Purpura Following BNT162b2 mRNA Coronavirus Disease Vaccination in a Japanese Patient.
    Yoshida K; Sakaki A; Matsuyama Y; Mushino T; Matsumoto M; Sonoki T; Tamura S
    Intern Med; 2022 Feb; 61(3):407-412. PubMed ID: 34803105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.